経営計画・資本政策の見直し/2025-10-31
実施中
公表資料を発表・実施・結果の順に記録しています。この表示は選定した案件の調査状況であり、会社全体の評価ではありません。
FY2025–FY2027 IC-package substrate investment program
IBIDEN reiterated approximately ¥100bn of annual capex and a target to more than double SAP capacity by the end of FY2027; FY2025 ROE subsequently reached 12.2%.
時系列と出典(2件・内容は原文)
- 2025-10-31Capex and capacity path reiterated The company said FY2025–FY2027 capex would average about ¥100bn annually and SAP capacity would more than double by end-FY2027. 出典資料1
- 2026-03-31(公表 2026-05-11)FY2025 results reported IBIDEN reported ¥416.2bn sales, ¥62.0bn operating profit and 12.2% ROE. 出典資料1
経営陣が表明したこと
IBIDEN plans roughly ¥100bn of annual capex through FY2027 and more than twice the prior SAP capacity by end-FY2027.
会社の開示資料による ・ 出典資料1
実際に行ったこと・時期
FY2025 sales, operating profit and ROE improved, but plant-level spend and utilization are not fully reconciled.
一部開示(不足あり) ・ 出典資料1
経済性について開示したこと
The rationale is AI-server and ASIC substrate demand; project hurdle rates and downside cases are not disclosed.
一部開示(不足あり) ・ 出典資料1
残る論点
Investor question: What customer commitments and project returns support the capacity doubling? IR preparation: publish plant-level spend, qualification, utilization and ROIC.
当調査の分析(会社の説明ではありません)